Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of african children

Clinical Infectious Diseases

Volumn 52, Issue 9, 2011, Pages 1100-1107

  Hendriksen, Ilse C E ^a,b   Mtove, George ^d   Pedro, Alínia José ^f   Gomes, Ermelinda ^f   Silamut, Kamolrat ^a   Lee, Sue J ^a,b   Mwambuli, Abraham ^e   Gesase, Samwel ^d   Reyburn, Hugh ^c,e   Day, Nicholas P J ^a,b   White, Nicholas J ^a,b   Von Seidlein, Lorenz ^g   Dondorp, Arjen M ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^e Joint Malaria Programme   (Tanzania)

^f Hospital Central da Beira   (Mozambique)

^g MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMODIUM FALCIPARUM HISTIDINE RICH PROTEIN2; PLASMODIUM LACTATE DEHYDROGENASE; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; HRP 2 ANTIGEN, PLASMODIUM FALCIPARUM; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; LACTATE DEHYDROGENASE; PARASITE ANTIGEN;

ANALYTICAL EQUIPMENT; ANTIGEN DETECTION; ARTICLE; BLOOD SMEAR; CHILD; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROSCOPY; MOZAMBIQUE; NEGRO; PLASMODIUM FALCIPARUM; PREDICTIVE VALUE; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; TANZANIA; EVALUATION; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; METHODOLOGY; PARASITOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; TIME;

ANTIGENS, PROTOZOAN; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; INFANT; L-LACTATE DEHYDROGENASE; MALARIA, FALCIPARUM; MALE; MICROSCOPY; MOZAMBIQUE; PLASMODIUM FALCIPARUM; PREDICTIVE VALUE OF TESTS; PROTOZOAN PROTEINS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TANZANIA; TIME FACTORS;

EID: 79953896041     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir143     Document Type: Article

References (44)

1. English M, Punt J, Mwangi I, McHugh K, Marsh K. Clinical overlap between malaria and severe pneumonia in Africa children in hospital. Trans R Soc Trop Med Hyg 1996; 90:658-62. (Pubitemid 27011161)
2. Molyneux E, Walsh A, Phiri A, Molyneux M. Acute bacterial meningitis in children admitted to the Queen Elizabeth Central hospital, Blantyre, Malawi in 1996-97. Trop Med Int Health 1998; 3:610-8. (Pubitemid 28394590)
3. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39-47. (Pubitemid 40075679)
4. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995; 332:1399-404.
5. Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376:1647-57.
6. Reyburn H, Mbatia R, Drakeley C, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004; 329:1212.
7. World Health Organization (WHO). Guidelines for the treatment of malaria. Geneva, Switzerland: WHO, 2010. ISBN 9241546948.
8. McMorrow ML, Masanja MI, Abdulla SM, Kahigwa E, Kachur SP. Challenges in routine implementation and quality control of rapid diagnostic tests for malaria-Rufiji District, Tanzania. Am J Trop Med Hyg 2008; 79:385-90.
9. Nankabirwa J, Zurovac D, Njogu JN, et al. Malaria misdiagnosis in Uganda-implications for policy change. Malar J 2009; 8:66.
10. World Health Organization (WHO). Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: round (2008). Geneva, Switzerland: WHO, 2009. Available at: http://www.finddiagnostics.org/ resourcecentre/reports-brochures/malaria- diagnostics-report-2009.html Accessed 14 November 2010.
11. World Health Organization (WHO). Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: round (2009). Geneva, Switzerland: WHO, 2010. Available at: http://www.finddiagnostics.org/ resourcecentre/reports-brochures/malaria- diagnostic-test-report-round2.html. Accessed 14 November 2010.
12. Birku Y, Welday D, Ayele D, Shepherd A. Rapid diagnosis of severe malaria based on the detection of Pf-Hrp-2 antigen. Ethiop Med J 1999; 37:173-9.
13. Maxwell CA, Chambo W, Mwaimu M, Magogo F, Carneiro IA, Curtis CF. Variation of malaria transmission and morbidity with altitude in Tanzania and with introduction of alphacypermethrin treated nets. Malar J 2003; 2:28.
14. Nadjm B, Amos B, Mtove G, et al. WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmo-dium falciparum transmission: prospective study. BMJ 2010; 340:c1350.
15. Alonso PL, Sacarlal J, Aponte JJ, et al. Duration of protection with RTS, S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 2005; 366:2012-2018. (Pubitemid 41773376)
16. Brentlinger PE, Behrens CB, Kublin JG. Challenges in the prevention, diagnosis, and treatment of malaria in human immunodeficiency virus infected adults in sub-Saharan Africa. Arch Intern Med 2007; 167:1827-36. (Pubitemid 47481477)
17. World Health Organization (WHO). Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000; 94(Suppl. 1):S1-S90.
18. World Health Organziation (WHO). Basic malaria microscopy. Geneva, Switzerland: WHO, 1991. ISBN 9241544309.
19. Newcombe RG. Simultaneous comparison of sensitivity and specificity of two tests in the paired design: a straightforward graphical approach. Stat Med 2001; 20:907-15. (Pubitemid 32249089)
20. World Health Organization (WHO). Malaria rapid diagnosis: Making it work. Meeting report 20-23 January. Geneva, Switzerland: WHO, 2003. Available at: http://who.int/malaria/publications/atoz/rdt2/en Accessed 19 April 2010.
21. Gwer S, Newton CR, Berkley JA. Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. Am J Trop Med Hyg 2007; 77(6 Suppl):6-13.
22. Berkley JA, Bejon P, Mwangi T, et al. HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis 2009; 49:336-43.
23. D'Acremont V, Lengeler C, Genton B. Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review. Malar J 2010; 9:240.
24. Dondorp AM, Lee SJ, Faiz MA, et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis 2008; 47:151-7. (Pubitemid 351920613)
25. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997; 349:1650-4. (Pubitemid 27234806)
26. Shujatullah F, Malik A, Khan HM, Malik A. Comparison of different diagnostic techniques in Plasmodium falciparum cerebral malaria. J Vector Borne Dis 2006; 43:186-90. (Pubitemid 44901462)
27. World Health Organization (WHO). Information note on interim selection criteria for procurement of malaria rapid diagnostic tests (RDTs). Geneva, Switzerland: WHO, 2010. Available at: http://www.who. int/malaria/diagnosis- treatment/diagnosis/RDT-selection-criteria.pdf Accessed 14 November 2010.
28. Bojang KA. The diagnosis of Plasmodium falciparum infection in Gambian children, by field staff using the rapid, manual, ParaSight-F test. Ann Trop Med Parasitol 1999; 93:685-7. (Pubitemid 29527689)
29. Kyabayinze DJ, Tibenderana JK, Odong GW, Rwakimari JB, Counihan H. Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda. Malar J 2008; 7:221.
30. Mawilimboumba DP, Bouyou Akotet MK, Ngoungou EB, Kombila M. Evaluation of rapid diagnostic tests for malaria case management in Gabon. Diagn Microbiol Infect Dis 2009; 66:162-8.
31. Ashley EA, Touabi M, Ahrer M, et al. Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar J 2009; 8:241.
32. Ochola LB, Vounatsou P, Smith T, Mabaso ML, Newton CR. The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence of a gold standard. Lancet Infect Dis 2006; 6:582-8.
33. Hopkins H, Kambale W, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ. Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda. Am J Trop Med Hyg 2007; 76:1092-7. (Pubitemid 351837871)
34. Mayxay M, Pukrittayakamee S, Chotivanich K, Looareesuwan S, White NJ. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Trans R Soc Trop Med Hyg 2001; 95:179-82. (Pubitemid 34947382)
35. Iqbal J, Siddique A, Jameel M, Hira PR. Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection. J Clin Microbiol 2004; 42:4237-41. (Pubitemid 39296150)
36. Swarthout TD, Counihan H, Senga RK, van den Broek I. Paracheck-Pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? Malar J 2007; 6:58.
37. Oduola AM, Omitowoju GO, Sowunmi A, et al. Plasmodium falcipa-rum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Exp Parasitol 1997; 87:283-9. (Pubitemid 27494333)
38. Hayward RE, Sullivan DJ, Day KP. Plasmodium falciparum: histidine-rich protein II is expressed during gametocyte development. Exp Parasitol 2000; 96:139-46. (Pubitemid 32050464)
39. Tjitra E, Suprianto S, McBroom J, Currie BJ, Anstey NM. Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with game-tocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence. J Clin Microbiol 2001; 39:1025-31. (Pubitemid 32209716)
40. Gillet P, Mori M, Van Esbroeck M, Van den Ende J, Jacobs J. Assessment of the prozone effect in malaria rapid diagnostic tests. Malar J 2009; 8:271.
41. Lee N, Baker J, Andrews KT, et al. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: implications for rapid diagnostic tests for malaria. J Clin Microbiol 2006; 44:2773-8. (Pubitemid 44228570)
42. Baker J, McCarthy J, Gatton M, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis 2005; 192:870-7. (Pubitemid 41193085)
43. Mariette N, Barnadas C, Bouchier C, Tichit M, Menard D. Countrywide assessment of the genetic polymorphism in Plasmodium falcipa-rum and Plasmodium vivax antigens detected with rapid diagnostic tests for malaria. Malar J 2008; 7:219.
44. de Oliveira AM, Skarbinski J, Ouma PO, et al. Performance of malaria rapid diagnostic tests as part of routine malaria case management in Kenya. Am J Trop Med Hyg 2009; 80:470-4.